Saturday 23 August 2014
 
»
Tag
 
»
GSK

PE firms mull $10bn merger of older GSK, Sanofi brands

Private equity firms are mulling over a $10 billion plan to buy and merge older drug brands of Britain's GlaxoSmithKline and France's Sanofi, the Financial Times reported on Sunday, citing sources. U.S.-based KKR and Warbu

More…

FDA approves GSK's Tanzeum for diabetes

The US Food and Drug Administration approved GlaxoSmithKline's Tanzeum injection for treating adults with type 2 diabetes, in combination with diet and exercise. Tanzeum will carry a warning on its label that tumors of the thy

More…

GSK to invest $200m in African factories, R&D

Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as it bets on the importance of the continent in driving long-term demand for medicine. The decision reflects the

More…

GSK heart drug misses goal in major study

An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major late-stage clinical study, dealing a blow to one of the company's biggest new treatment hopes. Darapla

More…

GSK aims to market world's first malaria vaccine

British drugmaker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children.   Th

More…

China launches crackdown on pharmaceutical sector

China announced a nationwide crackdown on the sale of illegal medicine on Wednesday and said it would tighten industry regulation, piling pressure on a sector already reeling from a bribery scandal at British drugmaker GlaxoSmithKline.

More…

GSK used travel agencies for China bribes: police'

Chinese police on Monday accused British drugmaker GlaxoSmithKline of channelling bribes to Chinese officials and doctors through travel agencies for six years to illegally boost sales and to raise the price of its medicines in the country.

More…

GSK's new HIV drug matches rival

A new once-daily Aids drug from GlaxoSmithKline and its partner Shionogi proved just as good as Merck & Co's twice-daily rival Isentress in a late-stage clinical trial, boosting hopes for the product. Both GSK's new drug dolutegravir a

More…

GSK to showcase at Dubai dental expo

GlaxoSmithKline (GSK) will showcase its product range at the UAE International Dental Conference and Arab Dental Exhibition – AEEDC Dubai 2012, which opened in Dubai today (January 31). The 16th edition of the show is being held at the Dub

More…

Cervical cancer vaccines 'very effective'

Using GlaxoSmithKline's  Cervarix vaccine to protect girls against the HPV virus that causes cervical cancer is so effective that health authorities could reduce the need for later cervical screening, scientists said on Wednesday.

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads